Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank85
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
12.93
↑ 130% vs avg
Percentile
P85
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
5.62
Historical baseline
PeriodValueYoY Change
202512.93-
20240.00-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00+100.0%
2017-0.05-100.1%
201643.29-